TP53 and non-small cell lung carcinoma: Also, miR-1246 has been identified as a novel p53 target miRNA, as shown by the study of Liao et al., who reported p53 to inhibit DYRK1A expression through the induction of miR-1246 in non-small-cell lung cancer cells [23].